Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 30779529

Pembrolizumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
N Engl J Med
Publication date
2019 Mar 21
First author
Rini BI

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    N Engl J Med. 2019 Mar 21;380(12):1176-1178. doi: 10.1056/NEJMe1900887.
    note
    Source null
    related pmid
    30779526
    relationship
    Comment in
  2. citation
    Cancer Discov. 2019 Apr;9(4):460. doi: 10.1158/2159-8290.CD-NB2019-024.
    note
    Source null
    related pmid
    30787015
    relationship
    Comment in
  3. citation
    Eur Urol. 2019 Jul;76(1):126-127. doi: 10.1016/j.eururo.2019.03.002.
    note
    Source null
    related pmid
    30879791
    relationship
    Comment in
  4. citation
    N Engl J Med. 2019 Jun 27;380(26):2581. doi: 10.1056/NEJMc1905518.
    note
    Source null
    related pmid
    31242369
    relationship
    Comment in
  5. citation
    N Engl J Med. 2019 Jun 27;380(26):2582. doi: 10.1056/NEJMc1905518.
    note
    Source null
    related pmid
    31242371
    relationship
    Comment in

Authors and identifiers

  1. name
    Rini BI
    type
    Author
  2. name
    Plimack ER
    type
    Author
  3. name
    Stus V
    type
    Author
  4. name
    Gafanov R
    type
    Author
  5. name
    Hawkins R
    type
    Author
  6. name
    Nosov D
    type
    Author
  7. name
    Pouliot F
    type
    Author
  8. name
    Alekseev B
    type
    Author
  9. name
    Soulières D
    type
    Author
  10. name
    Melichar B
    type
    Author
  11. name
    Vynnychenko I
    type
    Author
  12. name
    Kryzhanivska A
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Rini BI
    type
    Author
  2. name
    Plimack ER
    type
    Author
  3. name
    Stus V
    type
    Author
  4. name
    Gafanov R
    type
    Author
  5. name
    Hawkins R
    type
    Author
  6. name
    Nosov D
    type
    Author
  7. name
    Pouliot F
    type
    Author
  8. name
    Alekseev B
    type
    Author
  9. name
    Soulières D
    type
    Author
  10. name
    Melichar B
    type
    Author
  11. name
    Vynnychenko I
    type
    Author
  12. name
    Kryzhanivska A
    type
    Author
bibliography ids
  1. nci-bib-a6753bf79b1fa9a22399fe2b
book metadata
content sha256
e025f88b3b318377aeb45474a1ef32e506ba9352a9d0af4f147acc6796094fc2
document type
citation
dois
  1. 10.1056/NEJMoa1816714
electronic publication date
display
2019 Feb 16
precision
day
year
2019
evidence scope
bibliographic_metadata_only
id
pubmed:30779529
immutable id
pubmed:30779529@e025f88b3b318377aeb45474a1ef32e506ba9352a9d0af4f147acc6796094fc2
journal
abbreviation
N Engl J Med
issn electronic
1533-4406
issn print
0028-4793
issue
12
name
The New England journal of medicine
nlm unique id
0255562
pages
1116-1127
volume
380
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    N Engl J Med. 2019 Mar 21;380(12):1176-1178. doi: 10.1056/NEJMe1900887.
    note
    Source null
    related pmid
    30779526
    relationship
    Comment in
  2. citation
    Cancer Discov. 2019 Apr;9(4):460. doi: 10.1158/2159-8290.CD-NB2019-024.
    note
    Source null
    related pmid
    30787015
    relationship
    Comment in
  3. citation
    Eur Urol. 2019 Jul;76(1):126-127. doi: 10.1016/j.eururo.2019.03.002.
    note
    Source null
    related pmid
    30879791
    relationship
    Comment in
  4. citation
    N Engl J Med. 2019 Jun 27;380(26):2581. doi: 10.1056/NEJMc1905518.
    note
    Source null
    related pmid
    31242369
    relationship
    Comment in
  5. citation
    N Engl J Med. 2019 Jun 27;380(26):2582. doi: 10.1056/NEJMc1905518.
    note
    Source null
    related pmid
    31242371
    relationship
    Comment in
outcomes validated
false
pmid
30779529
provenance
batch id
e808962322f3afebc564
provider
NCBI PubMed ESummary
record sha256
c5e8e5f053b2ae530ed0285941e992cd94fd056bd9ced22b5564ca7ff507434c
response sha256
3d610336ca8dae92b82cdb6b3ee6cab382eb509e0349b0c68c261b042b036561
retrieved at
2026-09-09T23:47:41.002093+00:00
publication date
display
2019 Mar 21
precision
day
year
2019
publication types
  1. Clinical Trial, Phase III
  2. Comparative Study
  3. Journal Article
  4. Multicenter Study
  5. Randomized Controlled Trial
  6. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/30779529/
title
Pembrolizumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma.

Preserved source evidence · Not medical advice